Discovery 

YDL Ventures is in collaboration with Eurofins Discovery, a world leading contract research organization (CRO). Through this partnership YDL can optimize your discovery process - whether you need complete, end-to-end services, help with one or more stages, or the products for discovery work. With over 600 scientists around the world, 50 patents, and 30 billion data points screened, you can rely on Eurofins Discovery to provide you with the deep resources needed for your success.

​

Standalone Services

 

Offering the ability to support your projects on an as-needed basis across the drug discovery workflow Eurofins Discovery offer you services for Medicinal Chemistry, Synthetic Chemistry, In Vitro Pharmacology, Safety & Efficacy, ADME & Toxicology, Phenotypic Assays, and in vivo.

​

Eurofins Discovery has supported Drug Discovery research for over 40 years. They are recognized as the industry leader for providing drug discovery researchers the largest and most diverse portfolio of standard and custom in vitro safety & pharmacology assays and panels for drug screening and profiling.

​

In addition to in vitro safety pharmacology strengths, Eurofins Discovery also offer a broad portfolio of over 3500 drug discovery services and 1800 products. These include medicinal and synthetic chemistry, in vitro pharmacology, safety pharmacology & efficacy, ADME-Tox, cell-based phenotypic assays, and custom proteins and assay development capabilities. Eurofins Discovery support a variety of drug discovery targets such as GPCRs, Kinases, Ion Channels, Nuclear Hormone Receptors, and other proteins & enzymes.